Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal function as a predictor of irinotecan-induced neutropenia.
de Jong FA, van der Bol JM, Mathijssen RH, van Gelder T, Wiemer EA, Sparreboom A, Verweij J. de Jong FA, et al. Among authors: van der bol jm, van gelder t. Clin Pharmacol Ther. 2008 Aug;84(2):254-62. doi: 10.1038/sj.clpt.6100513. Epub 2008 Feb 20. Clin Pharmacol Ther. 2008. PMID: 18288083
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
Hesselink DA, van Schaik RH, van der Heiden IP, van der Werf M, Gregoor PJ, Lindemans J, Weimar W, van Gelder T. Hesselink DA, et al. Among authors: van der werf m, van gelder t, van schaik rh, van der heiden ip. Clin Pharmacol Ther. 2003 Sep;74(3):245-54. doi: 10.1016/S0009-9236(03)00168-1. Clin Pharmacol Ther. 2003. PMID: 12966368
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
Hesselink DA, van Gelder T, van Schaik RH, Balk AH, van der Heiden IP, van Dam T, van der Werf M, Weimar W, Mathot RA. Hesselink DA, et al. Among authors: van dam t, van gelder t, van der werf m, van schaik rh, van der heiden ip. Clin Pharmacol Ther. 2004 Dec;76(6):545-56. doi: 10.1016/j.clpt.2004.08.022. Clin Pharmacol Ther. 2004. PMID: 15592326
Time-dependent clearance of mycophenolic acid in renal transplant recipients.
van Hest RM, van Gelder T, Bouw R, Goggin T, Gordon R, Mamelok RD, Mathot RA. van Hest RM, et al. Among authors: van gelder t. Br J Clin Pharmacol. 2007 Jun;63(6):741-52. doi: 10.1111/j.1365-2125.2006.02841.x. Epub 2007 Jan 3. Br J Clin Pharmacol. 2007. PMID: 17214827 Free PMC article.
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
Heijns JB, van der Burg ME, van Gelder T, Fieren MW, de Bruijn P, van der Gaast A, Loos WJ. Heijns JB, et al. Among authors: van gelder t, van der gaast a, van der burg me. Cancer Chemother Pharmacol. 2008 Oct;62(5):841-7. doi: 10.1007/s00280-007-0671-9. Epub 2008 Jan 19. Cancer Chemother Pharmacol. 2008. PMID: 18204842 Free PMC article.
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T. van Agteren M, et al. Among authors: van der werf m, van gelder t, van schaik rh. Ther Drug Monit. 2008 Aug;30(4):439-44. doi: 10.1097/FTD.0b013e318180c709. Ther Drug Monit. 2008. PMID: 18641546 Clinical Trial.
Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA. de Winter BC, et al. Among authors: van gelder t, van hest rm. Clin Pharmacokinet. 2008;47(12):827-38. doi: 10.2165/0003088-200847120-00007. Clin Pharmacokinet. 2008. PMID: 19026038
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Schmidt J, Budde K, Kuypers D, Le Meur Y, van der Werf M, Mamelok R, van Gelder T. van Schaik RH, et al. Among authors: van agteren m, van der werf m, van gelder t. Clin Pharmacol Ther. 2009 Sep;86(3):319-27. doi: 10.1038/clpt.2009.83. Epub 2009 Jun 3. Clin Pharmacol Ther. 2009. PMID: 19494809 Clinical Trial.
482 results